Position in DCTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$357,502
-$169,112 QoQ
Shares Held
38,524
-26.1% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DCTH Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $877,721,958 across 43 Medical Devices names. DCTH ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
762,096 | $250,249,463 | |
| 2 | MASI |
Masimo Corp
|
770,986 | $137,135,279 | |
| 3 | ABT |
Abbott Laboratories
|
844,451 | $86,699,784 | |
| 4 | BSX |
Boston Scientific Corp
|
1,356,133 | $85,097,345 | |
| 5 | BRKR |
Bruker Corp
|
1,159,040 | $41,864,524 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
424,578 | $38,390,342 | |
| 7 | AXGN |
Axogen, Inc.
|
1,087,066 | $36,014,495 | |
| 8 | DXCM |
Dexcom Inc
|
566,312 | $35,564,393 |
All Filings in DCTH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $357,502 | 38,524 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $526,614 | 52,140 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $330,627 | 30,756 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $602,765 | 47,350 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||